P Simioni Selected Research

P Simioni Research Topics

Disease

12	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020 - 03/2000
12	Venous Thromboembolism 09/2014 - 01/2000
8	Activated Protein C Resistance (APC Resistance) 01/2012 - 01/2000
7	Thrombosis (Thrombus) 01/2018 - 01/2000
6	Thrombophilia 07/2020 - 01/2000
6	Hemorrhage 01/2020 - 02/2001
4	Protein S Deficiency (Deficiency, Protein S) 01/2017 - 07/2005
3	Factor V Deficiency 07/2018 - 05/2011
2	Neoplasms (Cancer) 01/2018 - 10/2013
2	Fibrosis (Cirrhosis) 02/2013 - 09/2012
2	Thromboembolism 12/2008 - 10/2001
1	Acromegaly 07/2020
1	Atrial Fibrillation 01/2020
1	Ascites 01/2017
1	Parkinson Disease (Parkinson's Disease) 01/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016
1	Wounds and Injuries (Trauma) 12/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2014
1	Cushing Syndrome 02/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2013
1	Hemophilia A (Haemophilia) 01/2013
1	Liver Diseases (Liver Disease) 09/2012
1	Hemorrhagic Disorders (Hemorrhagic Diathesis) 05/2012
1	Acquired Protein S Deficiency 02/2010
1	Empyema 05/2008
1	Pneumonia (Pneumonitis) 05/2008
1	Hyperprothrombinemia 05/2007
1	Critical Illness (Critically Ill) 08/2003
1	Pulmonary Embolism 08/2003
1	Hemolysis 01/2002
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2001
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2001
1	Factor XII Deficiency 04/2000
1	Peripheral Arterial Disease 04/2000
1	Congenital Plasminogen Deficiency 01/2000
1	hereditary Thrombophilia 01/2000
1	Disease Susceptibility (Diathesis) 01/2000

Drug/Important Bio-Agent (IBA)

13	factor V LeidenIBA 01/2017 - 01/2000
10	Prothrombin (Factor II)IBA 09/2014 - 01/2000
9	Factor V (Coagulation Factor V)IBA 07/2018 - 08/2000
9	Protein CIBA 01/2012 - 01/2000
6	Thrombin FDA Link 07/2020 - 12/2005
5	AnticoagulantsIBA 01/2020 - 08/2003
4	Protein SIBA 04/2010 - 07/2002
3	AntithrombinsIBA 02/2013 - 07/2005
3	Blood Coagulation Factors (Coagulation Factor)IBA 05/2011 - 11/2000
2	Fibrinogen (Factor I)FDA Link 07/2020 - 01/2002
2	Factor VIIa (Activated Factor VII)IBA 01/2018 - 02/2013
2	Thromboplastin (Tissue Factor)IBA 01/2018 - 01/2012
2	AntigensIBA 01/2016 - 01/2000
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 09/2012 - 08/2003
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 04/2010 - 02/2010
2	Oral ContraceptivesIBA 03/2001 - 03/2000
1	ThrombomodulinIBA 07/2020
1	Factor VIII (Coagulation Factor VIII)IBA 07/2020
1	RivaroxabanIBA 01/2020
1	Everolimus FDA Link 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2020
1	FibrinIBA 01/2018
1	Colloids (Colloid)IBA 01/2017
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 10/2013
1	platelet factor VIBA 03/2012
1	fibrin fragment D (D-dimer)IBA 05/2008
1	Heparin (Liquaemin)FDA LinkGeneric 08/2003
1	coumarinIBA 08/2003
1	HaptoglobinsIBA 01/2002
1	Antithrombin IIIIBA 01/2002
1	Fibronectins (Fibronectin)IBA 01/2002
1	Factor VaIBA 10/2001
1	Factor X (Stuart Factor)IBA 02/2001
1	Ticlopidine (Ticlid)FDA LinkGeneric 04/2000
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2000
1	Dipyridamole (Persantine)FDA LinkGeneric 04/2000
1	PlasminogenIBA 01/2000

Therapy/Procedure

4	Therapeutics 01/2013 - 03/2000
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2016
1	Transplantation 01/2016
1	Liver Transplantation 12/2014
1	Contraception (Birth Control) 05/2001
1	Endarterectomy (Thromboendarterectomy) 04/2000
1	Conservative Treatment 04/2000